...
首页> 外文期刊>Journal of cardiovascular electrophysiology >The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients.
【24h】

The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients.

机译:肝素化患者在射频导管消融期间血小板功能,凝血和纤维蛋白溶解的激活。

获取原文
获取原文并翻译 | 示例

摘要

INTRODUCTION: Catheter ablation may be complicated by clinical thromboembolism in about 1% of patients. METHODS AND RESULTS: We studied the activation of coagulation (prothrombin fragment 1+2 [PF1+2]), platelets (beta-thromboglobulin [beta-TG])) and fibrinolysis (plasmin-antiplasmin complexes [PAP] and D-dimer) during radiofrequency (RF) ablation in 13 patients. They received heparin 100 U/kg intravenously after the initial electrophysiologic study, prior to the delivery of RF current; thereafter 1,000 U/hour throughout the procedure. PF1+2 increased fourfold (P < 0.001) during the diagnostic study, but gradually declined to upper reference value during heparin administration. There was a strong correlation between procedure duration prior to heparin bolus (range 39 to 173 min); and (a) the maximal rise of PF1+2 (r = 0.83, P < 0.001) and (b) the increase of PF1+2 from baseline to end of the procedure (r = 0.74, P = 0.004). There was no correlation between postheparin changes of PF1+2 and (a) postheparin procedure duration (range 40 to 317 min), (b) number of RF pulses (range 1 to 16), or (c) RF current duration (range 46 to 687 sec). Plasma beta-TG concentration showed similar trends. Fibrinolytic activity increased moderately from baseline until heparin administration; then remained around the upper reference values. PAP at the end of procedure and D-dimer at the time of heparin administration both correlated with preheparin procedure duration (r = 0.70, P = 0.007 and r = 0.69, P = 0.01, respectively). All parameters were normal the next morning. CONCLUSION: Procedure duration prior to heparin administration, and not the delivery of RF current per se, determines activation of hemostasis and fibrinolysis during RF ablation.
机译:简介:大约有1%的患者会因临床血栓栓塞而导致导管消融。方法和结果:我们研究了凝血(凝血酶原片段1 + 2 [PF1 + 2]),血小板(β-凝血球蛋白[β-TG])和纤维蛋白溶解(纤溶酶-抗纤溶酶复合物[PAP]和D-二聚体)的激活作用。射频(RF)消融治疗期间13例患者。在最初的电生理研究之后,在射频电流释放之前,他们静脉内接受了100 U / kg肝素。此后整个过程为1,000 U /小时。在诊断研究期间,PF1 + 2增加了四倍(P <0.001),但在肝素给药期间逐渐下降至较高参考值。肝素推注之前的手术持续时间之间有很强的相关性(范围39至173分钟)。 (a)PF1 + 2的最大上升(r = 0.83,P <0.001),以及(b)从基线到手术结束时PF1 + 2的最大上升(r = 0.74,P = 0.004)。 PF1 + 2的肝素后变化与(a)肝素后过程持续时间(范围40至317分钟),(b)RF脉冲数(范围1至16)或(c)RF电流持续时间(范围46)之间没有相关性至687秒)。血浆β-TG浓度显示出相似的趋势。从基线到肝素给药为止,纤溶活性逐渐增加。然后保持在较高参考值附近。手术结束时的PAP和肝素给药时的D-二聚体均与肝素注射前的手术持续时间相关(分别为r = 0.70,P = 0.007和r = 0.69,P = 0.01)。第二天早上所有参数均正常。结论:肝素给药前的手术时间长短,而不是射频电流本身的传递,决定了射频消融过程中止血和纤维蛋白溶解的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号